Edition:
United Kingdom

People: ANI Pharmaceuticals Inc (ANIP.OQ)

ANIP.OQ on NASDAQ Stock Exchange Global Market

67.51USD
5:24pm BST
Change (% chg)

$-0.03 (-0.04%)
Prev Close
$67.54
Open
$67.44
Day's High
$68.76
Day's Low
$67.44
Volume
12,208
Avg. Vol
50,501
52-wk High
$86.67
52-wk Low
$39.83

Przybyl, Arthur 

Mr. Arthur S. Przybyl is President, Chief Executive Officer, Director of the Company. Mr. Przybyl is an experienced healthcare executive in a career that spans over 25 years and includes the management of both specialty pharmaceutical and medical device companies. From August 2002 through January 2009, Mr. Przybyl served as President and Chief Executive Officer of Akorn, Inc., a NASDAQ-listed specialty pharmaceutical company that manufactures and markets ophthalmic, liquid and lyophilized injectable, and vaccine drug products. Prior to Akorn, Mr. Przybyl was President of privately-held company Hearing Innovations, Inc. and President and Chief Operating Officer of NASDAQ-listed company Bioject, Inc., both of which are medical device companies. During his career, Mr. Przybyl has held several sales and marketing management positions, including Senior Vice President, Sales and Marketing for International Medication Systems, Inc. and Director, Corporate Marketing and National Accounts for LyphoMed, Inc., both specialty pharmaceutical companies.

Basic Compensation

Total Annual Compensation, USD 1,401,920
Restricted Stock Award, USD 1,660,450
Long-Term Incentive Plans, USD --
All Other, USD 1,135,560
Fiscal Year Total, USD 4,197,930

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 69,624 3,428,600.00
Name Fiscal Year Total

Robert Brown

273,573

Arthur Przybyl

4,197,930

Stephen Carey

1,438,750

Robert Schrepfer

1,444,160

James Marken

1,009,590

Thomas Haughey

252,569
As Of  31 Dec 2018